- Home
- URG vs ORIC Comparison
URG vs ORIC Comparison
Compare URG & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- URG
- ORIC
- Stock Information
- Founded
- URG 2004
- ORIC 2014
- Country
- URG United States
- ORIC United States
- Employees
- URG N/A
- ORIC N/A
- Industry
- URG Precious Metals
- ORIC Biotechnology: Pharmaceutical Preparations
- Sector
- URG Basic Materials
- ORIC Health Care
- Exchange
- URG Nasdaq
- ORIC Nasdaq
- Market Cap
- URG 339.5M
- ORIC 362.9M
- IPO Year
- URG N/A
- ORIC 2020
- Fundamental
- Price
- URG $1.06
- ORIC $9.35
- Analyst Decision
- URG Strong Buy
- ORIC Strong Buy
- Analyst Count
- URG 2
- ORIC 8
- Target Price
- URG $2.45
- ORIC $18.83
- AVG Volume (30 Days)
- URG 8.5M
- ORIC 2.1M
- Earning Date
- URG 08-08-2025
- ORIC 08-11-2025
- Dividend Yield
- URG N/A
- ORIC N/A
- EPS Growth
- URG N/A
- ORIC N/A
- EPS
- URG N/A
- ORIC N/A
- Revenue
- URG $33,706,000.00
- ORIC N/A
- Revenue This Year
- URG N/A
- ORIC N/A
- Revenue Next Year
- URG $251.38
- ORIC N/A
- P/E Ratio
- URG N/A
- ORIC N/A
- Revenue Growth
- URG 200.09
- ORIC N/A
- 52 Week Low
- URG $0.55
- ORIC $3.90
- 52 Week High
- URG $1.53
- ORIC $14.67
- Technical
- Relative Strength Index (RSI)
- URG 65.53
- ORIC 62.84
- Support Level
- URG $0.90
- ORIC $8.85
- Resistance Level
- URG $1.14
- ORIC $9.54
- Average True Range (ATR)
- URG 0.08
- ORIC 0.74
- MACD
- URG 0.02
- ORIC -0.07
- Stochastic Oscillator
- URG 82.48
- ORIC 50.98
About URG Ur Energy Inc (Canada)
Ur-Energy Inc is engaged in uranium mining and recovery operations, with activities including the acquisition, exploration, development, and production of uranium mineral resources located in Wyoming. The company owns and operates the Lost Creek in-situ recovery uranium facility in south-central Wyoming, Lost Creek received an amendment to its license allowing the expansion of mining activities within the existing Lost Creek Project and the adjacent LC East Project.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.